Briacell Therapeutics Corp (BCTX) — Strategic Asset Allocation Index
Briacell Therapeutics Corp (BCTX) has a Strategic Asset Allocation Index of 3.2% as of April 2026. Strategic assets (PP&E of $- plus long-term investments of $750.98K) total $750.98K, measured against net assets of $23.41 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. For live market cap and overall valuation, see Briacell Therapeutics Corp market cap and net worth.
SAAI
Strategic Assets
PP&E
Net Assets
Briacell Therapeutics Corp Strategic Asset Allocation Index (2017–2022)
This chart shows how Briacell Therapeutics Corp's Strategic Asset Allocation Index has evolved across 4 annual periods from 2017 to 2022. As of April 2026, the index stands at 3.2%, representing strategic assets of $750.98K against net assets of $23.41 Million USD. See net asset quality index of Briacell Therapeutics Corp to measure how much of total assets are equity-financed.
Annual Strategic Asset Allocation Index for Briacell Therapeutics Corp (2017–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Briacell Therapeutics Corp from 2017 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. Also explore BCTX year-over-year net asset growth to track the company's year-over-year net asset growth rate.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.0% | $2.00 | $- | $2.00 | $13.25 Million | ▲ +0.0 pp |
| 2021 | 0.0% | $2.00 | $- | $2.00 | $34.58 Million | ▼ 0.0 pp |
| 2018 | 0.0% | $2.00 | $- | $2.00 | $945.02K | ▼ 0.0 pp |
| 2017 | 0.0% | $2.00 | $- | $2.00 | $750.23K | — |